Cerdeira, A., O'Sullivan, J., Ohuma, E., James, T., Papageorghiou, A., Knight, M., & Vatish, M. (2021). Ruling out preeclampsia in the next 4 weeks using a soluble fms-like tyrosine kinase 1/placental growth factor ratio ≤38: Secondary analysis of the Interventional Study on Prediction of Preeclampsia/Eclampsia in Women With Suspected Preeclampsia. Elsevier.
Cytowanie według stylu Chicago (wyd. 17)Cerdeira, AS, J. O'Sullivan, EO Ohuma, T. James, AT Papageorghiou, M. Knight, i M. Vatish. Ruling Out Preeclampsia in the Next 4 Weeks Using a Soluble Fms-like Tyrosine Kinase 1/placental Growth Factor Ratio ≤38: Secondary Analysis of the Interventional Study on Prediction of Preeclampsia/Eclampsia in Women With Suspected Preeclampsia. Elsevier, 2021.
Cytowanie według stylu MLA (wyd. 9)Cerdeira, AS, et al. Ruling Out Preeclampsia in the Next 4 Weeks Using a Soluble Fms-like Tyrosine Kinase 1/placental Growth Factor Ratio ≤38: Secondary Analysis of the Interventional Study on Prediction of Preeclampsia/Eclampsia in Women With Suspected Preeclampsia. Elsevier, 2021.